Search

Your search keyword '"Jansåker F"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Jansåker F" Remove constraint Author: "Jansåker F" Database MEDLINE Remove constraint Database: MEDLINE
37 results on '"Jansåker F"'

Search Results

1. Population-based risk factors and urogenital comorbidities associated with genital herpes: A nationwide study of 4 million women.

2. Vulvovaginal candidiasis and type 2 diabetes: A nationwide retrospective cohort study.

3. Examining the influence of Covid-19 restrictions, a nurse strike, and SARS-CoV-2 coinfection on bacteremia mortality: A Danish population-based cohort study (2019-2022).

4. Neighbourhood deprivation and type 2 diabetes in patients with bipolar disorder: A nationwide follow-up study.

5. Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden.

6. Association between neighborhood deprivation and mortality in patients with schizophrenia and bipolar disorder-A nationwide follow-up study.

7. Neighborhood deprivation in relation to lung cancer in individuals with type 2 diabetes-A nationwide cohort study (2005-2018).

8. The effects of sociodemographic factors and comorbidities on sepsis: A nationwide Swedish cohort study.

9. A longitudinal study of the association between attending cultural events and coronary heart disease.

10. Examining the causal effect of type 2 diabetes on ischemic heart disease - A longitudinal study with four measurements (1980-2017).

11. Association between attending cultural events and all-cause mortality: a longitudinal study with three measurements (1982-2017).

12. Cervical neoplasia in relation to socioeconomic and demographic factors - a nationwide cohort study (2002-2018).

13. The relation of body mass index, body height, and parity to pyelonephritis: A nationwide population-based cohort study of over one million parous women (1997-2018).

14. The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study.

15. Neighborhood deprivation and coronary heart disease in patients with bipolar disorder.

16. The association between common urogenital infections and cervical neoplasia - A nationwide cohort study of over four million women (2002-2018).

17. Novel risk factors associated with common vaginal infections: a nationwide primary health care cohort study: Novel risk factors for vaginal infections.

18. Elucidating the effect of body mass index, height, and parity on uncomplicated cystitis: a nationwide population-based cohort study.

19. Fluoroquinolones and Other Antibiotics Redeemed for Cystitis-A Swedish Nationwide Cohort Follow-Up Study (2006-2018).

20. Sociodemographic Disparities and Parity in Relation to Urinary Incontinence: A Nationwide Primary Healthcare Cohort Study (1997-2018).

21. The Effect of Sociodemographic Factors, Parity and Cervical Cancer on Antibiotic Treatment for Uncomplicated Cystitis in Women: A Nationwide Cohort Study.

22. All-cause Mortality Due to Bacteremia during a 60-Day Non-Physician Healthcare Worker Strike.

23. Sociodemographic factors and uncomplicated pyelonephritis in women aged 15-50 years: a nationwide Swedish cohort register study (1997-2018).

24. Decrease in All-Cause 30-Day Mortality after Bacteraemia over a 15-Year Period: A Population-Based Cohort Study in Denmark in 2000-2014.

25. Sociodemographic factors and uncomplicated cystitis in women aged 15-50 years: a nationwide Swedish cohort registry study (1997-2018).

26. Prevalence and recurrence of bacteraemia in hospitalised people who inject drugs - a single Centre retrospective cohort study in Denmark.

27. Retrospective study of men with E. coli UTI treated with an oral antibiotic, and risk for a new prescription or hospital admission due to UTI.

28. Mutational change of CTX-M-15 to CTX-M-127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient.

29. ESBL-production in Escherichia coli and Klebsiella pneumoniae isolates from Nigeria.

30. Treatment duration of pivmecillinam in men, non-pregnant and pregnant women for community-acquired urinary tract infections caused by Escherichia coli: a retrospective Danish cohort study.

31. Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial.

32. Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli , ESBL-producing or not - a retrospective cohort study.

33. Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort.

34. Pivmecillinam for Uncomplicated Lower Urinary Tract Infections Caused by Staphylococcus saprophyticus -Cumulative Observational Data from Four Recent Clinical Studies.

35. Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review.

36. The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections - a randomized, double-blinded, placebo-controlled clinical trial study protocol.

37. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.

Catalog

Books, media, physical & digital resources